Francesca Ceccherini Silberstein
Francesca Ceccherini Silberstein
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
2019 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, F Ceccherini-Silberstein, C Charpentier, ...
Topics in antiviral medicine 27 (3), 111, 2019
Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients
M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ...
The Journal of infectious diseases 211 (2), 178-186, 2015
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
AM Vandamme, RJ Camacho, F Ceccherini-Silberstein, A De Luca, ...
Aids Rev 13 (2), 77-108, 2011
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018
MC Sorbo, V Cento, VC Di Maio, AYM Howe, F Garcia, CF Perno, ...
Drug Resistance Updates 37, 17-39, 2018
Characterization and structural analysis of HIV-1 integrase conservation
F Ceccherini-Silberstein, I Malet, R D’Arrigo, A Antinori, AG Marcelin, ...
Aids Rev 11 (1), 17-29, 2009
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 …
A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ...
Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015
Functional characterization of substance P receptors on cultured human spinal cord astrocytes: synergism of substance P with cytokines in inducing interleukin‐6 and …
C Palma, L Minghetti, M Astolfi, E Ambrosini, F Ceccherini Silberstein, ...
Glia 21 (2), 183-193, 1997
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors
V Cento, C Mirabelli, R Salpini, S Dimonte, A Artese, G Costa, F Mercurio, ...
PloS one 7 (7), e39652, 2012
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors
V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ...
Journal of virology 80 (14), 7186-7198, 2006
Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies
VC Di Maio, V Cento, I Lenci, M Aragri, P Rossi, S Barbaliscia, M Melis, ...
Liver international 37 (4), 514-528, 2017
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study
RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ...
The Lancet 376 (9738), 340-345, 2010
Non-AIDS defining cancers in the D: A: D Study-time trends and predictors of survival: a cohort study
SW Worm, M Bower, P Reiss, F Bonnet, M Law, G Fätkenheuer, ...
BMC infectious diseases 13, 1-15, 2013
Emerging patterns and implications of HIV-1 integrase inhibitor resistance
AM Geretti, D Armenia, F Ceccherini-Silberstein
Current opinion in infectious diseases 25 (6), 677-686, 2012
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection
V Svicher, V Cento, M Bernassola, M Neumann-Fraune, F Van Hemert, ...
Antiviral research 93 (1), 86-93, 2012
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure
F Ceccherini-Silberstein, F Erba, F Gago, A Bertoli, F Forbici, ...
Aids 18 (12), 11-19, 2004
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades
T Doyle, DT Dunn, F Ceccherini-Silberstein, C De Mendoza, F Garcia, ...
Journal of Antimicrobial Chemotherapy 70 (11), 3080-3086, 2015
Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes
E Ludwig, FC Silberstein, J van Empel, V Erfle, M Neumann, ...
Journal of virology 73 (10), 8279-8289, 1999
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
I Malet, L Gimferrer Arriaga, A Artese, G Costa, L Parrotta, S Alcaro, ...
Journal of Antimicrobial Chemotherapy 69 (8), 2118-2122, 2014
Understanding HIV compartments and reservoirs
V Svicher, F Ceccherini-Silberstein, A Antinori, S Aquaro, CF Perno
Current HIV/AIDS Reports 11, 186-194, 2014
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to …
F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ...
Journal of virology 81 (20), 11507-11519, 2007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20